447 related articles for article (PubMed ID: 15254781)
1. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
[TBL] [Abstract][Full Text] [Related]
2. Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.
Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
J Gastroenterol; 2004 Sep; 39(9):851-8. PubMed ID: 15565404
[TBL] [Abstract][Full Text] [Related]
3. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
5. B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.
Fan Y; Jiang WZ; Wen JJ; Hao WL; Du JN; Liu X; Qian M
Arch Virol; 2009; 154(11):1813-21. PubMed ID: 19838621
[TBL] [Abstract][Full Text] [Related]
6. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
[TBL] [Abstract][Full Text] [Related]
7. Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressed murine hepatitis B virus carrier: evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo.
Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
Immunobiology; 2004; 209(7):551-7. PubMed ID: 15568619
[TBL] [Abstract][Full Text] [Related]
8. Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.
Fazle Akbar SM; Furukawa S; Yoshida O; Hiasa Y; Horiike N; Onji M
J Hepatol; 2007 Jul; 47(1):60-6. PubMed ID: 17467112
[TBL] [Abstract][Full Text] [Related]
9. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
10. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
[TBL] [Abstract][Full Text] [Related]
11. Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection.
Akbar SM; Yoshida O; Chen S; Cesar AJ; Abe M; Matsuura B; Hiasa Y; Onji M
Antivir Ther; 2010; 15(6):887-95. PubMed ID: 20834101
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B.
Akbar SM; Furukawa S; Horiike N; Abe M; Hiasa Y; Onji M
J Viral Hepat; 2011 Jun; 18(6):408-14. PubMed ID: 20487261
[TBL] [Abstract][Full Text] [Related]
13. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
[TBL] [Abstract][Full Text] [Related]
14. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
15. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
Desombere I; Willems A; Gijbels Y; Leroux-Roels G
J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
[TBL] [Abstract][Full Text] [Related]
16. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
Li X; Yang X; Jiang Y; Liu J
Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice.
Jiang WZ; Fan Y; Liu X; Zhang YL; Wen JJ; Hao WL; Qian M
Antiviral Res; 2008 Jan; 77(1):50-5. PubMed ID: 17897731
[TBL] [Abstract][Full Text] [Related]
18. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
[TBL] [Abstract][Full Text] [Related]
19. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice].
Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577
[TBL] [Abstract][Full Text] [Related]
20. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]